Saurabh Datta is a seasoned leader in the field of cardiovascular imaging and medical devices, currently serving as a pivotal figure at Abbott in the Advanced Imaging and Structural Heart division. With over 15 years of experience, Saurabh has honed his expertise in R&D, signal...
Saurabh Datta is a seasoned leader in the field of cardiovascular imaging and medical devices, currently serving as a pivotal figure at Abbott in the Advanced Imaging and Structural Heart division. With over 15 years of experience, Saurabh has honed his expertise in R&D, signal processing, and product development, making significant contributions to the commercialization of innovative medical solutions. His role involves leading clinical engineering teams across a diverse portfolio of structural heart product development programs, including transcatheter mitral and tricuspid valve repair and replacement (TMVR/TTVR), transcatheter aortic valve interventions (TAVI/TAVR), left atrial appendage closure (LAAC), and surgical valves.
Saurabh's strategic vision and customer-focused approach have been instrumental in generating substantial business value, bridging the gap between engineering and commercial functions. He has successfully navigated the complexities of international marketing and product management, ensuring that Abbott's cutting-edge technologies reach global markets effectively. His ability to synthesize market research with innovative product strategies has led to the successful launch of multiple products that address critical needs in cardiovascular care.
In addition to his technical acumen, Saurabh is adept at fostering collaboration among cross-functional teams, driving initiatives that enhance product performance and patient outcomes. His commitment to advancing cardiovascular health through innovative medical devices positions him as a thought leader in the industry, dedicated to improving the lives of patients worldwide. As he continues to lead transformative projects at Abbott, Saurabh Datta remains at the forefront of the evolving landscape of cardiovascular therapies, leveraging his extensive experience to shape the future of heart health.
